StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
Publishing Date
2022 - 02 - 23
6
2022 - 02 - 22
3
Sector
Health technology
3
Manufacturing
1
Producer manufacturing
4
Technology services
1
Tags
100
4
Acquisition
14
Air
5
Als
25
America
4
Application
5
Approval
7
Bioscience
5
Biotech-bay
5
Cel
22
Ces
121
Collaboration
5
Commercialization
4
Conference
40
Corporation
20
Covid
7
Covid-19
7
Day
14
Device
6
Disease
5
Earnings
11
Ema
5
Energy
16
Events
4
Expansion
4
Fda
6
Financial results
71
Genomic
6
Genomics
6
Group
23
Growth
24
Health
37
Intel
5
Liver
8
Media
7
N/a
512
Nasdaq
5
Offering
8
One
11
Partnership
10
People
5
Program
6
Report
112
Research
15
Results
128
Sales
6
Security
7
Services
11
Set
10
Solutions
8
Star
5
State
7
System
20
Technology
14
Test
10
Thc
7
Therapeutics
13
Trial
9
Vaccine
5
Work
11
Entities
Cnh industrial n.v.
2
Cytokinetics, incorporated
1
Horizon therapeutics public limited company
1
Marinus pharmaceuticals, inc.
1
Mymd pharmaceuticals inc
1
Otis worldwide corporation
1
Parker-hannifin corporation
1
Veeva systems inc.
1
Symbols
CNHI
2
CYTK
1
HZNP
1
MRNS
1
MYMD
1
OTIS
1
PH
1
VEEV
1
Exchanges
Nasdaq
4
Nyse
5
Crawled Date
2023 - 12 - 12
15
2023 - 12 - 11
18
2023 - 10 - 24
17
2023 - 10 - 23
16
2023 - 09 - 26
16
2023 - 09 - 11
16
2023 - 06 - 05
20
2023 - 05 - 25
23
2022 - 12 - 08
20
2022 - 06 - 06
21
2022 - 05 - 23
15
2022 - 03 - 16
15
2022 - 03 - 01
17
2022 - 02 - 28
15
2022 - 02 - 15
15
2022 - 01 - 18
16
2022 - 01 - 04
15
2021 - 12 - 16
16
2021 - 12 - 14
15
2021 - 12 - 13
28
2021 - 12 - 09
21
2021 - 12 - 06
24
2021 - 11 - 30
15
2021 - 11 - 16
18
2021 - 11 - 15
17
2021 - 11 - 09
15
2021 - 11 - 08
19
2021 - 11 - 03
19
2021 - 10 - 28
17
2021 - 10 - 27
15
2021 - 10 - 25
17
2021 - 10 - 20
16
2021 - 10 - 14
18
2021 - 10 - 13
19
2021 - 10 - 12
15
2021 - 10 - 07
19
2021 - 09 - 28
15
2021 - 09 - 13
27
2021 - 09 - 09
16
2021 - 09 - 08
20
2021 - 08 - 31
15
2021 - 07 - 27
16
2021 - 07 - 15
15
2021 - 07 - 07
15
2021 - 07 - 06
17
2021 - 06 - 28
22
2021 - 06 - 25
15
2021 - 06 - 24
15
2021 - 06 - 23
24
2021 - 06 - 16
16
2021 - 06 - 07
21
2021 - 05 - 12
15
2021 - 04 - 15
16
2021 - 04 - 12
16
2021 - 03 - 18
17
2021 - 03 - 15
15
2020 - 12 - 10
16
2020 - 12 - 09
20
2020 - 12 - 03
22
2020 - 12 - 01
23
Crawled Time
00:00
3
12:30
2
13:30
1
18:00
1
19:00
1
22:00
1
Source
www.biospace.com
4
www.globenewswire.com
3
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Trial
crawled date :
2022 - 02 - 23
save search
Parker Scheduled to Present at the Evercore ISI Industrial Conference on February 28 at 9:40 a.m. Eastern Time
Published:
2022-02-23
(Crawled : 22:00)
- globenewswire.com
PH
|
$540.57
-0.66%
0.0%
510K
|
Producer Manufacturing
|
86.45%
|
O:
-2.24%
H:
2.32%
C:
2.03%
trial
conference
Horizon Therapeutics plc Initiates Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating Teprotumumab for the Treatment of Active Thyroid Eye Disease (TED)
Published:
2022-02-23
(Crawled : 19:00)
- biospace.com/
HZNP
|
$116.3
0.03%
29M
|
Health Technology
|
25.38%
|
O:
0.97%
H:
0.38%
C:
-2.35%
treatment
eye
eye disease
trial
therapeutics
disease
active
phase 3
MyMD Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan
Published:
2022-02-23
(Crawled : 18:00)
- biospace.com/
MYMD
|
$2.1
0.0%
45K
|
Manufacturing
|
-45.26%
|
O:
0.49%
H:
2.91%
C:
-9.93%
health
phase 2
als
trial
therapy
enroll
Cytokinetics Announces Start of SEQUOIA-HCM, a Phase 3 Clinical Trial of Aficamten in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Published:
2022-02-23
(Crawled : 13:30)
- biospace.com/
CYTK
|
$67.94
-1.54%
-1.56%
1.3M
|
Health Technology
|
104.81%
|
O:
0.0%
H:
1.25%
C:
-6.95%
cardio
trial
star
phase 3
Industry Leaders to Come Together to Advance Digital Trials at Veeva TMF Innovation Forum
Published:
2022-02-23
(Crawled : 12:30)
- prnewswire.com
VEEV
|
News
|
$199.2
-0.58%
0.0%
1M
|
Technology Services
|
-8.32%
|
O:
0.77%
H:
0.2%
C:
-4.42%
als
trials
trial
Otis to Attend Barclays Industrial Select Conference
Published:
2022-02-23
(Crawled : 12:30)
- prnewswire.com
OTIS
|
$94.96
-1.06%
0.0%
2.3M
|
Producer Manufacturing
|
24.46%
|
O:
0.62%
H:
0.04%
C:
-2.71%
trial
conference
Follow Live Today: CNH Industrial Capital Markets Day
Published:
2022-02-22
(Crawled : 00:00)
- globenewswire.com
CNHI
|
News
|
$12.36
-1.51%
-0.08%
8M
|
Producer Manufacturing
|
-19.22%
|
O:
-3.95%
H:
2.88%
C:
-1.13%
day
trial
oda
CNH Industrial Ventures established to accelerate new technology adoption and nurture disruptive innovation
Published:
2022-02-22
(Crawled : 00:00)
- globenewswire.com
CNHI
|
News
|
$12.36
-1.51%
-0.08%
8M
|
Producer Manufacturing
|
-19.22%
|
O:
-3.95%
H:
2.88%
C:
-1.13%
technology
trial
cel
new technology
Marinus Pharmaceuticals Announces Delay to RAISE Phase 3 Clinical Trial in Status Epilepticus and Associated IV Ganaxolone Clinical Trials
Published:
2022-02-22
(Crawled : 00:00)
- biospace.com/
MRNS
|
$1.45
20.83%
17.24%
10M
|
Health Technology
|
-87.14%
|
O:
-1.16%
H:
2.26%
C:
0.99%
epilepticus
als
trials
trial
one
clinical trials
phase 3
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.